𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of ciprofibrate in hyperlipoproteinaemias

✍ Scribed by Gérard Turpin; Eric Bruckert


Book ID
118326395
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
424 KB
Volume
124
Category
Article
ISSN
0021-9150

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Therapeutic efficacy of the HMG-CoA-redu
✍ H. Saxenhofer; P. Weidmann; W. F. Riesen; C. Beretta-Piccoli; C. Fragiacomo; R. 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 533 KB

The efficacy and safety of the HMG-CoA-reductase inhibitor pravastatin was assessed in a double-blind, placebo controlled study. Thirty patients (51 y) with hyperlipoproteinaemia Type IIa (N = 22) or IIb (N = 8) received for 16 weeks either pravastatin 5 mg b.d. for 8 weeks followed by 10 mg b.d. fo